IP Library Granted Patent US 8,623,995
Granted Patent B2
US 8,623,995 · App. 12/814,642 · Granted Jan 7, 2014

Peptide conjugates and fluorescence detection methods for intracellular caspase assay

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,623,995
App. No.
12/814,642
Granted
Jan 7, 2014
Kind
B2
Abstract

Polypeptides labelled with a donor and acceptor pair of dyes selected from a dibenzorhodamine dye and a diamino-benzophenoxazine dye are peptide conjugates which are useful for intracellular and bead-based assays with fluorescence detection. Peptide conjugates with a caspase-recognition site undergo cleavage into peptide fragments which may be detected, located, and quantitated by the changes in fluorescence. Intracellular cleavage of peptide conjugates is correlated with apoptosis.

Claims (24)

1. A method of synthesizing a peptide conjugate comprising:

a) synthesizing a polypeptide on a solid support, wherein the polypeptide comprises the amino acid sequence, Gly-Asp-Glu-Val-Asp-Gly-Ile-Lys (SEQ ID NO. 2);

b) reacting the polypeptide on a solid support with a first dye labelling reagent;

c) cleaving the polypeptide from the solid support; and

d) reacting the cleaved polypeptide with a second dye labelling reagent;

wherein the first dye labelling reagent is of the formula:

wherein R 13 , R 14 , R 15 , and R 16 are selected from hydrogen, C 1 -C 12 alkyl, C 1 -C 12 alkyldiyl, phenyl, substituted phenyl, benzyl, substituted benzyl, biphenyl, substituted biphenyl, naphthyl, substituted naphthyl, heterocycle, substituted heterocycle, a water-solubilizing group and a linking moiety;

R 13 when taken together with R 14 is C 2 -C 8 alkyldiyl;

R 15 when taken together with R 16 is C 2 -C 8 alkyldiyl;

R 13 when taken together with R 17 is C 2 -C 8 alkyldiyl;

R 15 when taken together with R 22 is C 2 -C 8 alkyldiyl;

R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , and R 26 are selected from hydrogen, fluorine, chlorine, bromine, C 1 -C 8 alkyl, carboxylate, sulfate, sulfonate, alkylsulfonate, aminomethyl (—CH 2 NH 2 ), aminoalkyl, 4-dialkylaminopyridinium, hydroxymethyl (—CH 2 OH), methoxy (—OCH 3 ), hydroxyalkyl (—ROH), thiomethyl (—CH 2 SH), thioalkyl (—RSH), alkylsulfone (—SO 2 R), arylthio (—SAr), arylsulfone (—SO 2 Ar), sulfonamide (—SO 2 NR 2 ), alkylsulfoxide (—SOR), arylsulfoxide (—SOAr), primary amino (—NH 2 ), ammonium (—NH 3 + ), secondary amino (—NHR), tertiary amino (—NR 2 ), quaternary amine (—NR 3 + ), amido (—CONR 2 ), nitrile (—CN), nitro (—NO 2 ), C 1 -C 8 alkoxy (—OR), phenoxy, phenolic, tolyl, phenyl, C 5 -C 20 aryl, benzyl, heterocycle, phosphonate, phosphate, sulfate, polyethyleneoxy, a water-solubilizing group, and a linking moiety, wherein R is selected from C 1 -C 6 alkyl and C 1 -C 6 alkyldiyl, and Ar is C 5 -C 14 aryl;

R 19 and R 20 , when taken together, are C 5 -C 14 aryleno;

R 24 and R 25 , when taken together, are C 5 -C 14 aryleno;

with the proviso that at least one of R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , and R 26 is a linking moiety; and the second labelling reagent is of the formula:

wherein R 1 , R 2 , R 3 , and R 4 are selected from hydrogen, C 1 -C 12 alkyl, C 1 -C 12 alkyldiyl, phenyl, substituted phenyl, benzyl, substituted benzyl, biphenyl, substituted biphenyl, naphthyl, substituted naphthyl, heterocycle, substituted heterocycle, a water-solubilizing group, and a linking moiety;

R 1 when taken together with R 2 is C 2 -C 8 alkyldiyl;

R 3 when taken together with R 4 is C 2 -C 8 alkyldiyl;

R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 are selected from hydrogen, fluorine, chlorine, bromine, C 1 -C 8 alkyl, carboxylate, sulfate, sulfonate, alkylsulfonate, aminomethyl (—CH 2 NH 2 ), aminoalkyl, 4-dialkylaminopyridinium, hydroxymethyl (—CH 2 OH), methoxy (—OCH 3 ), hydroxyalkyl (—ROH), thiomethyl (—CH 2 SH), thioalkyl (—RSH), alkylsulfone (—SO 2 R), arylthio (—SAr), arylsulfone (—SO 2 Ar), sulfonamide (—SO 2 NR 2 ), alkylsulfoxide (—SOR), arylsulfoxide (—SOAr), primary amino (—NH 2 ), ammonium (—NH 3 + ), secondary amino (—NHR), tertiary amino (—NR 2 ), quaternary amine (—NR 3 + ), amido (—CONR 2 ), nitrile (—CN), nitro (—NO 2 ), C 1 -C 8 alkoxy (—OR), phenoxy, phenolic, tolyl, phenyl, C 5 -C 20 aryl, benzyl, heterocycle, phosphonate, phosphate, sulfate, polyethyleneoxy, a water-solubilizing group, and a linking moiety, wherein R is selected from C 1 -C 6 alkyl and C 1 -C 6 alkyldiyl, and Ar is C 5 -C 14 aryl;

R 6 and R 7 , when taken together, is C 5 -C 14 aryleno;

R 10 and R 11 , when taken together, is C 5 -C 14 aryleno;

with the proviso that at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 is a linking moiety;

whereby a peptide conjugate is formed.

2. A kit comprising the peptide conjugate of claim 1 and a plurality of eukaryotic cells.